Top Markets
Coin of the day
INOVIQ Ltd INOVIQ Ltd

INOVIQ Ltd

IIQ
Rankning i aktier #29964
INOVIQ Ltd specializes in the research, development, and commercialization of... INOVIQ Ltd specializes in the research, development, and commercialization of diagnostic and exosome-based products, aiming to improve the detection and treatment of cancer and other conditions across Australia and the United States. Its current portfolio includes the hTERT test, an immunocytochemistry assay that serves as a supplementary tool for urine cytology in bladder cancer screening, alongside EXO-NET, designed for the capture and isolation of exosomes from liquid biopsy specimens. The company also boasts a robust diagnostic pipeline, featuring blood tests currently under development for various cancers, including ovarian and breast cancer. Originally incorporated in 1983 and formerly known as BARD1 Life Sciences Limited until its rebranding to INOVIQ Ltd in December 2021, the company maintains its headquarters in Notting Hill, Australia.
Aktiekurs
$0.13400411
Marknadsvärde
$18.86M
Förändring (1 dag)
2.70%
Förändring (1 år)
-48.10%
Land
AU
Handel INOVIQ Ltd (IIQ)

Kategori

Historik för aktiesplit för INOVIQ Ltd (IIQ)
Aktien INOVIQ Ltd (symbol: IIQ) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 19, 2026.
En IIQ-aktie köpt före Aug 19, 2026 motsvarar nu 0 IIQ-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US